Daily inhalation of hydrogen gas has a blood pressure-lowering effect in a rat model of hypertension

被引:19
|
作者
Sugai, Kazuhisa [1 ]
Tamura, Tomoyoshi [1 ,2 ,3 ]
Sano, Motoaki [1 ,3 ,4 ]
Uemura, Shizuka [1 ]
Fujisawa, Masahiko [1 ]
Katsumata, Yoshinori [3 ,4 ]
Endo, Jin [3 ,4 ]
Yoshizawa, Joe [2 ]
Homma, Koichiro [2 ,3 ]
Suzuki, Masaru [3 ,5 ]
Kobayashi, Eiji [1 ,3 ,6 ]
Sasaki, Junichi [2 ,3 ]
Hakamata, Yoji [1 ,3 ]
机构
[1] Nippon Vet & Life Sci Univ, Sch Vet Nursing & Technol, Dept Basic Sci, Tokyo 1808602, Japan
[2] Keio Univ, Dept Emergency & Crit Care Med, Sch Med, Tokyo 1608582, Japan
[3] Keio Univ, Ctr Mol Hydrogen Med, Tokyo 1088345, Japan
[4] Keio Univ, Dept Cardiol, Sch Med, Tokyo 1608582, Japan
[5] Ichikawa Gen Hosp, Dept Emergency Med, Tokyo Dent Coll, Chiba 1608582, Japan
[6] Keio Univ, Dept Organ Fabricat, Sch Med, Tokyo 1608582, Japan
基金
日本学术振兴会;
关键词
CHRONIC KIDNEY-DISEASE; NEURAL MECHANISMS; OXIDATIVE STRESS; ISCHEMIA; BRAIN;
D O I
10.1038/s41598-020-77349-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A recent clinical study demonstrated that haemodialysis with a dialysate containing hydrogen (H-2) improves blood pressure control in end-stage kidney disease. Herein, we examined whether H-2 has a salutary effect on hypertension in animal models. We subjected 5/6 nephrectomised rats to inhalation of either H-2 (1.3% H-2+21% O-2+77.7% N-2) or control (21% O-2+79% N-2) gas mixture for 1 h per day. H-2 significantly suppressed increases in blood pressure after 5/6 nephrectomy. The anti-hypertensive effect of H-2 was also confirmed in rats in a stable hypertensive state 3 weeks after nephrectomy. To examine the detailed effects of H-2 on hypertension, we used an implanted telemetry system to continuously monitor blood pressure. H-2 exerted an anti-hypertensive effect not only during daytime rest, but also during night-time activities. Spectral analysis of blood pressure variability revealed that H-2 improved autonomic imbalance, namely by suppressing the overly active sympathetic nervous system and augmenting parasympathetic nervous system activity; these effects co-occurred with the blood pressure-lowering effect. In conclusion, 1-h daily exposure to H-2 exerts an anti-hypertensive effect in an animal model of hypertension.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Neuroprotective and Intraocular pressure-lowering effects of (-)Δ9-tetrahydrocannabinol in a rat model of glaucoma
    Crandall, James
    Matragoon, Suraporn
    Khalifa, Yousuf M.
    Borlongan, Caesar
    Tsai, Nai-Tse
    Caldwell, Ruth B.
    Liou, Gregory I.
    OPHTHALMIC RESEARCH, 2007, 39 (02) : 69 - 75
  • [42] Aerobic Exercise Training Enhances The Blood Pressure-lowering Effect Of Antihypertensive Medication.
    Ramirez-Jimenez, Miguel
    Morales-Palomo, Felix
    Moreno-Cabanas, Alfonso
    Ortega, Juan Fernando
    Alvarez-Jimenez, Laura
    Mora-Rodriguez, Ricardo
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2020, 52 (07) : 856 - 856
  • [43] Blood pressure-lowering effect of ER niacin and ER niacin/laropiprant in dyslipidemic patients
    Bays, Harold
    Maccubbin, Darbie
    Meehan, Alan
    Kuznetsova, Olga
    Mitchel, Yale
    Paolini, John F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A325 - A325
  • [44] The Blood Pressure-Lowering Effect of Orally Ingested Nitrite Is Abolished by a Proton Pump Inhibitor
    Montenegro, Marcelo F.
    Sundqvist, Michaela
    Larsen, Filip J.
    Zhuge, Zhengbing
    Carlstrom, Mattias
    Weitzberg, Eddie
    Lundberg, Jon O.
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 100 : S146 - S146
  • [45] Albuminuria-dependent effect of blood pressure-lowering drugs in preventing cardiovascular events
    Boersma, Cornelis
    Postma, Maarten J.
    Visser, Sipke T.
    de Jong, Paul E.
    de Jong-van den Berg, Lolkje T. W.
    Gansevoort, Ron T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S230 - S231
  • [46] Blood Pressure-Lowering Effect of Orally Ingested Nitrite Is Abolished by a Proton Pump Inhibitor
    Montenegro, Marcelo F.
    Sundqvist, Michaela L.
    Larsen, Filip J.
    Zhuge, Zhengbing
    Carlstrom, Mattias
    Weitzberg, Eddie
    Lundberg, Jon O.
    HYPERTENSION, 2017, 69 (01) : 23 - 31
  • [47] Cardiovascular Risk of Resistant Hypertension: Dependence on Treatment-Time Regimen of Blood Pressure-Lowering Medications
    Ayala, Diana E.
    Hermida, Ramon C.
    Mojon, Artemio
    Fernandez, Jose R.
    CHRONOBIOLOGY INTERNATIONAL, 2013, 30 (1-2) : 340 - 352
  • [48] Persistent olmesartan-based blood pressure-lowering effects on morning hypertension in Asians: the HONEST study
    Kario, Kazuomi
    Saito, Ikuo
    Kushiro, Toshio
    Teramukai, Satoshi
    Yaginuma, Mai
    Mori, Yoshihiro
    Okuda, Yasuyuki
    Kobayashi, Fumiaki
    Shimada, Kazuyuki
    HYPERTENSION RESEARCH, 2016, 39 (05) : 334 - 341
  • [49] Quadruple combination of quarter doses of blood pressure-lowering agents: a string QUARTET in the symphony of hypertension management?
    Volpe, Massimo
    Patrono, Carlo
    EUROPEAN HEART JOURNAL, 2021, 42 (48) : 4885 - 4886
  • [50] Blood pressure-lowering effects of biofeedback treatment in hypertension: a meta-analysis of randomized controlled trials
    Nakao, M
    Yano, E
    Nomura, S
    Kuboki, T
    HYPERTENSION RESEARCH, 2003, 26 (01) : 37 - 46